Medigus Stock Forecast - 20 Period Moving Average

MDGS Stock  USD 2.36  0.18  8.26%   
The 20 Period Moving Average forecasted value of Medigus Ltd ADR on the next trading day is expected to be 2.59 with a mean absolute deviation of  0.15  and the sum of the absolute errors of 6.04. Medigus Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Medigus stock prices and determine the direction of Medigus Ltd ADR's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Medigus' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Medigus' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Medigus' systematic risk associated with finding meaningful patterns of Medigus fundamentals over time.
Check out Historical Fundamental Analysis of Medigus to cross-verify your projections.
  
At this time, Medigus' Inventory Turnover is comparatively stable compared to the past year. Receivables Turnover is likely to gain to 4.61 in 2024, whereas Payables Turnover is likely to drop 2.86 in 2024. . Net Income Applicable To Common Shares is likely to gain to about 8.2 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 1.8 M in 2024.
Most investors in Medigus cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Medigus' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Medigus' price structures and extracts relationships that further increase the generated results' accuracy.
A commonly used 20-period moving average forecast model for Medigus Ltd ADR is based on a synthetically constructed Medigusdaily price series in which the value for a trading day is replaced by the mean of that value and the values for 20 of preceding and succeeding time periods. This model is best suited for price series data that changes over time.

Medigus 20 Period Moving Average Price Forecast For the 19th of April

Given 90 days horizon, the 20 Period Moving Average forecasted value of Medigus Ltd ADR on the next trading day is expected to be 2.59 with a mean absolute deviation of 0.15, mean absolute percentage error of 0.04, and the sum of the absolute errors of 6.04.
Please note that although there have been many attempts to predict Medigus Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Medigus' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Medigus Stock Forecast Pattern

Backtest MedigusMedigus Price PredictionBuy or Sell Advice 

Medigus Forecasted Value

In the context of forecasting Medigus' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Medigus' downside and upside margins for the forecasting period are 0.02 and 5.98, respectively. We have considered Medigus' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
2.36
2.59
Expected Value
5.98
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the 20 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Medigus stock data series using in forecasting. Note that when a statistical model is used to represent Medigus stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria78.0716
BiasArithmetic mean of the errors 0.1399
MADMean absolute deviation0.1473
MAPEMean absolute percentage error0.0574
SAESum of the absolute errors6.0385
The eieght-period moving average method has an advantage over other forecasting models in that it does smooth out peaks and valleys in a set of daily observations. Medigus Ltd ADR 20-period moving average forecast can only be used reliably to predict one or two periods into the future.

Predictive Modules for Medigus

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Medigus Ltd ADR. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Medigus' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.122.465.85
Details
Intrinsic
Valuation
LowRealHigh
0.122.315.70
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Medigus. Your research has to be compared to or analyzed against Medigus' peers to derive any actionable benefits. When done correctly, Medigus' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Medigus Ltd ADR.

Other Forecasting Options for Medigus

For every potential investor in Medigus, whether a beginner or expert, Medigus' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Medigus Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Medigus. Basic forecasting techniques help filter out the noise by identifying Medigus' price trends.

View Medigus Related Equities

 Risk & Return  Correlation

Medigus Ltd ADR Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Medigus' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Medigus' current price.

Medigus Market Strength Events

Market strength indicators help investors to evaluate how Medigus stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Medigus shares will generate the highest return on investment. By undertsting and applying Medigus stock market strength indicators, traders can identify Medigus Ltd ADR entry and exit signals to maximize returns.

Medigus Risk Indicators

The analysis of Medigus' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Medigus' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting medigus stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Medigus Ltd ADR is a strong investment it is important to analyze Medigus' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Medigus' future performance. For an informed investment choice regarding Medigus Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Medigus to cross-verify your projections.
Note that the Medigus Ltd ADR information on this page should be used as a complementary analysis to other Medigus' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Complementary Tools for Medigus Stock analysis

When running Medigus' price analysis, check to measure Medigus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medigus is operating at the current time. Most of Medigus' value examination focuses on studying past and present price action to predict the probability of Medigus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medigus' price. Additionally, you may evaluate how the addition of Medigus to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Is Medigus' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medigus. If investors know Medigus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medigus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(8.70)
Revenue Per Share
67.313
Quarterly Revenue Growth
0.527
Return On Assets
(0.07)
Return On Equity
(0.31)
The market value of Medigus Ltd ADR is measured differently than its book value, which is the value of Medigus that is recorded on the company's balance sheet. Investors also form their own opinion of Medigus' value that differs from its market value or its book value, called intrinsic value, which is Medigus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medigus' market value can be influenced by many factors that don't directly affect Medigus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medigus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Medigus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medigus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.